DAXTON 100 mg/ml solution for injection for cattle, pigs and sheep
DAXTON 100 mg/ml solution for injection for cattle, pigs and sheep
Authorised
- Tulathromycin
Product identification
Medicine name:
DAXTON 100 mg/ml solution for injection for cattle, pigs and sheep
Daxton, 100 mg/ml süstelahus veistele, sigadele ja lammastele
Active substance:
- Tulathromycin
Target species:
-
Cattle
-
Pig
-
Sheep
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Tulathromycin100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal22day
-
Milkno withdrawal periodNot authorised for use in animals producing milk for human consumption
-
-
-
Intramuscular use
-
Pig
-
Meat and offal13day
-
-
Sheep
-
Meat and offal16day
-
Milkno withdrawal periodNot authorised for use in animals producing milk for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA94
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- box with 1 vial 100 ml
- box with 1 vial 250 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Cenavisa S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Cenavisa S.L.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1173024
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0428/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Romania
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 17/12/2024
How useful was this page?: